PIB: A Score to Select Sorafenib Treatment Candidates for Hepatocellular Carcinoma in Resource-Limited Settings.
Leathers JS, Balderramo D, Prieto J, Diehl F, Gonzalez-Ballerga E, Ferreiro MR, Carrera E, Barreyro F, Diaz-Ferrer J, Singh D, Mattos AZ, Carrilho F, Debes JD.
Leathers JS, et al. Among authors: singh d.
Hepat Mon. 2018 Oct;18(10):e82345. doi: 10.5812/hepatmon.82345. Epub 2018 Oct 21.
Hepat Mon. 2018.
PMID: 30467514
Free PMC article.
No abstract available.